Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Indoxyl sulfate may be a therapeutic target for renal dysfunction-induced AF; hypothesis-generating and requires clinical validation.
Indoxyl sulfate facilitates atrial fibrosis and AF and thus is a novel therapeutic target for prevention of renal dysfunction-induced AF.
No takes yet. Share an insight, caveat, or question.
Aoki et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: